Posted By: Dan Limbach October 21, 2019The aim of this article is to discuss the current use of real-world data and evidence in health technology assessment (HTA) and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice (ISA) engagement can be used as a key tool in real-world evidence (RWE) generation planning.
October 21-22, 2019 in Washington, D.C. The Rare Summit affords an unprecedented opportunity to hear from the experts, including the heads of the three FDA medical centers, and join conversations of the pressing issues facing the rare disease community, including addressing affordability while sustaining innovation, creating a roadmap for collaboration between patient organizations and industry, plus conversations around gene therapy and rare cancers.
@stevenwdennis@TomG1033 Whoops. Same old, same old. The Packers laid the wood in the first half and did enough in the second half to get a double-digit win. Prescott makes some plays, but he has too many deficits. Wondering if these big games affect his contract.
@LelandRDaniel Packers have been on the wrong side of so many bad calls in big games, it is nice to see it go their way. The Fail Mary call ended ref strike, but it didn't give the Packers the win the refs stole. I don't like the new rule after scores, but that's what it is. #Packers#Vikings